Literature DB >> 16961279

Experimental study of tissue-type plasminogen activator gene to prevent vein grafts stenosis.

Xionggang Jiang1, Xiaobin Liu, Kailun Zhang, Jiahong Xia, Daokang Xiang, Long Wu, Cheng Zhou.   

Abstract

The effects of in vivo local expression of recombined human tissue-type plasminogen activator (t-PA) gene on the thrombosis and neointima formation of vein grafts were explored. Jugular vein-to-artery bypass grafting was performed on 72 New Zealand white rabbits. The rabbits were divided into 3 groups according to the different processing methods: transfected t-PA gene group (n = 24), vector group (n = 24) and blank control group (n = 24). Samples of vein grafts were harvested at different time points after surgery. The expression of t-PA gene in vein graft was detected by RT-PCR and the synthesis of t-PA protein by Western-Blot assay. The t-PA activity was measured by chromogenic substrate assay. The Cr51 labeled platelets accumulation in vein grafts was counted. The histopathological changes were compared in intima hyperplasia index among the three groups after operation. The results showed that at the 2nd, 5th, 14th and 28th day after operation, RT-PCR and Western-blot confirmed the expression of t-PA mRNA and protein at the site of gene transfer. The t-PA activity detected on the 2nd, 5th, 14th and 28th day in experimental group was 370.63 +/- 59.44, 344.13 +/- 48.47, 252.87 +/- 51.80 and 161.75 +/- 68.94 U/g respectively, and disappeared on the 60th day and undetected in the control groups. The number of platelets accumulated in the vein grafts in gene group, vector group and blank control group was (85.04 +/- 21.58) 10(6), (225.87 +/- 85.13) 10(6) and (211.7 +/- 78.02) 10(6) respectively. The number of platelets accumulated in gene group was significantly fewer than that in the control groups. Morphometric analysis revealed that intimal hyperplasia was markedly reduced in the t-PA gene group as compared with that in the control groups. It was suggested that the local expression of t-PA gene in vein graft significantly inhibited the accumulation of platelets, thrombosis and concomitant intimal hyperplasia, by which stenosis of bypass graft could be prevented effectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16961279     DOI: 10.1007/bf02829561

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  6 in total

1.  Plasminogen activator inhibitor-1 in neointima of vein grafts: its role in reduced fibrinolytic potential and graft failure.

Authors:  P Kauhanen; V Sirén; O Carpén; A Vaheri; M Lepäntalo; R Lassila
Journal:  Circulation       Date:  1997-09-16       Impact factor: 29.690

2.  Adventitial versus intimal liposome-mediated ex vivo transfection of canine saphenous vein grafts with endothelial nitric oxide synthase gene.

Authors:  M Kalra; C J Jost; S R Severson; V M Miller
Journal:  J Vasc Surg       Date:  2000-12       Impact factor: 4.268

Review 3.  Thrombolytic agents.

Authors:  Désiré Collen; H Roger Lijnen
Journal:  Thromb Haemost       Date:  2005-04       Impact factor: 5.249

4.  Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection.

Authors:  Evelyn Torsney; Ursula Mayr; Yiping Zou; W Douglas Thompson; Yanhua Hu; Qingbo Xu
Journal:  Circ Res       Date:  2004-04-29       Impact factor: 17.367

5.  Different mechanisms of increased luminal stenosis after arterial injury in mice deficient for urokinase- or tissue-type plasminogen activator.

Authors:  Katrin Schäfer; Stavros Konstantinides; Carsten Riedel; Therese Thinnes; Katja Müller; Claudia Dellas; Gerd Hasenfuss; David J Loskutoff
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

6.  Coronary bypass graft fate. Angiographic study of 1,179 vein grafts early, one year, and five years after operation.

Authors:  G M FitzGibbon; A J Leach; W J Keon; J R Burton; H P Kafka
Journal:  J Thorac Cardiovasc Surg       Date:  1986-05       Impact factor: 5.209

  6 in total
  1 in total

Review 1.  Gene therapy for the prevention of vein graft disease.

Authors:  Kevin W Southerland; Sarah B Frazier; Dawn E Bowles; Carmelo A Milano; Christopher D Kontos
Journal:  Transl Res       Date:  2012-12-27       Impact factor: 7.012

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.